81 related articles for article (PubMed ID: 34950454)
21. The cost-effectiveness of adding an ultrasound corticosteroid and local anaesthetic injection to advice and education for hip osteoarthritis.
Kigozi J; Oppong R; Paskins Z; Bromley K; Lewis M; Hughes G; Hughes E; Hennings S; Cherrington A; Hall A; Holden MA; Stevenson K; Menon A; Roberts P; Peat G; Jinks C; Foster NE; Mallen CD; Roddy E
Rheumatology (Oxford); 2023 Dec; ():. PubMed ID: 38085178
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial therapies for chronic pain (part 1): analgesic mechanisms.
Wang EJ; Karri J; Tontisirin N; Cohen SP
Korean J Pain; 2023 Jul; 36(3):281-298. PubMed ID: 37394272
[TBL] [Abstract][Full Text] [Related]
23. An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis.
Tenti S; Bruyère O; Cheleschi S; Reginster JY; Veronese N; Fioravanti A
Ther Adv Musculoskelet Dis; 2023; 15():1759720X231158618. PubMed ID: 36937821
[TBL] [Abstract][Full Text] [Related]
24. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
25. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of hydroxychloroquine
Ronaldson SJ; Keding A; Tharmanathan P; Arundel C; Kingsbury SR; Conaghan PG; Torgerson DJ
F1000Res; 2021; 10():821. PubMed ID: 34950454
[No Abstract] [Full Text] [Related]
27. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
28. Estimating Cost-Effectiveness Using Alternative Preference-Based Scores and Within-Trial Methods: Exploring the Dynamics of the Quality-Adjusted Life-Year Using the EQ-5D 5-Level Version and Recovering Quality of Life Utility Index.
Franklin M; Hunter RM; Enrique A; Palacios J; Richards D
Value Health; 2022 Jun; 25(6):1018-1029. PubMed ID: 35667775
[TBL] [Abstract][Full Text] [Related]
29. Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial.
Kingsbury SR; Tharmanathan P; Adamson J; Arden NK; Birrell F; Cockayne S; Dickson J; Doherty M; Dziedzic KS; Grainger A; Hewitt CE; O'Neill TW; Scott DL; Vincent TL; Wakefield RJ; Watt FE; Torgerson DJ; Conaghan PG
Trials; 2013 Mar; 14():64. PubMed ID: 23452375
[TBL] [Abstract][Full Text] [Related]
30. Economic costs, health-related quality of life outcomes and cost-utility of a physical and psychological group intervention targeted at older adults with neurogenic claudication.
Maredza M; Khan K; Marian IR; Dutton SJ; Williamson E; Lamb SE; Petrou S
Cost Eff Resour Alloc; 2023 Feb; 21(1):14. PubMed ID: 36755265
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial.
Pyne S; Sach TH; Lawrence M; Renz S; Eminton Z; Stuart B; Thomas KS; Francis N; Soulsby I; Thomas K; Permyakova NV; Ridd MJ; Little P; Muller I; Nuttall J; Griffiths G; Layton AM; Santer M
BMJ Open; 2023 Dec; 13(12):e073245. PubMed ID: 38081673
[TBL] [Abstract][Full Text] [Related]
32. Calculating and Interpreting ICERs and Net Benefit.
Paulden M
Pharmacoeconomics; 2020 Aug; 38(8):785-807. PubMed ID: 32390067
[TBL] [Abstract][Full Text] [Related]
33. Osteoarthritis in England: Incidence Trends From National Health Service Hospital Episode Statistics.
Morgan OJ; Hillstrom HJ; Ellis SJ; Golightly YM; Russell R; Hannan MT; Deland JT; Hillstrom R
ACR Open Rheumatol; 2019 Oct; 1(8):493-498. PubMed ID: 31777830
[TBL] [Abstract][Full Text] [Related]
34. Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis: A Randomized Trial.
Kingsbury SR; Tharmanathan P; Keding A; Ronaldson SJ; Grainger A; Wakefield RJ; Arundel C; Birrell F; Doherty M; Vincent T; Watt FE; Dziedzic K; O'Neill TW; Arden NK; Scott DL; Dickson J; Garrood T; Green M; Menon A; Sheeran T; Torgerson D; Conaghan PG
Ann Intern Med; 2018 Mar; 168(6):385-395. PubMed ID: 29459986
[TBL] [Abstract][Full Text] [Related]
35. Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis.
Machado GC; Maher CG; Ferreira PH; Day RO; Pinheiro MB; Ferreira ML
Ann Rheum Dis; 2017 Jul; 76(7):1269-1278. PubMed ID: 28153830
[TBL] [Abstract][Full Text] [Related]
36. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
